About this Series

Two noted oncologists bring current clinical evidence and their extensive clinical experience to the conundrum surrounding the management of metastatic renal cell carcinoma. The wealth of agents available for first-line, second-line, and third-line therapy, coupled with the lack of evidence supporting one therapy over another, has left oncologists facing an empiric treatment process.

Dr Brian Rini, from the Cleveland Clinic, and Dr Nicholas Vogelzang, from the Comprehensive Cancer Centers of Nevada, sort through the complexity of issues and offer oncologists practical guidance in managing patients with this devastating disease.

Show More

Who's Who
{{#each bp-whos-who.people}}
{{{name}}} {{{addComma prof}}}
{{#if disclosureTitle }} Disclosure
More on Renal Cell Carcinoma